MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Iradimed Corp Company Profile (NASDAQ:IRMD)

Consensus Ratings for Iradimed Corp (NASDAQ:IRMD) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.00 (10.00% upside)

Analysts' Ratings History for Iradimed Corp (NASDAQ:IRMD)
Show:
DateFirmActionRatingPrice TargetActions
6/16/2015Roth CapitalBoost Price TargetBuy$19.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Roth CapitalSet Price TargetBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Roth CapitalSet Price TargetBuy$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2014Roth CapitalBoost Price TargetBuy$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Roth CapitalInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha